Why is Brooks Lab. falling/rising?

As of 23-Sep, Brooks Laboratories Ltd is experiencing a decline in its stock price, currently at 145.95, which reflects a decrease of 1.6 or 1.08%. The stock has been underperforming, having fallen consecutively for the last six days, resulting in an overall drop of 8.21% during this period. Additionally, the stock's performance today has underperformed its sector by 0.73%. While the company reported very positive results with a significant net profit growth of 97.76% and has declared positive results for the last three consecutive quarters, the stock's long-term fundamental strength appears weak, with an average return on equity of 0% and a poor EBIT to interest ratio of -3.82. This combination of strong recent performance but weak long-term fundamentals may be contributing to the current downward price movement.
In the broader market context, the stock has underperformed compared to the Sensex, which has only declined by 0.34% over the past week while Brooks Laboratories Ltd has seen a much steeper decline of 6.08%. This stark contrast highlights the stock's struggles relative to the market. Furthermore, the company's liquidity remains adequate for trading, but a decrease in delivery volume by 7.75% against the five-day average indicates falling investor participation, which could further pressure the stock price. Overall, while there are positive indicators from recent earnings, the stock's persistent decline suggests that investor sentiment is currently cautious, influenced by its weak long-term growth prospects.